MedTrace Logo

Brain and Blood Vessel Health Following Endometriosis Treatment in People With Endometriosis

NCT07799246 · Status: NOT_YET_RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2026-09-02

No results posted yet for this study

Summary

This research study wants to understand how medications used to treatment symptoms of endometriosis impact brain health in patients with endometriosis.

Conditions

  • Endometriosis
  • Endometriosis and Dysmenorrhea
  • Endometriosis (Diagnosis)

Interventions

DRUG

Investigate how norethindrone acetate, a commonly used medication used to treat symptoms of endometriosis, impact biomarkers of brain health

Eligible participants will prospectively be randomized to one of three medications approved for the treatment of endometriosis symptoms.

DRUG

Investigate how Orlissa, a commonly used medication used to treat symptoms of endometriosis, impact biomarkers of brain health

Eligible participants will prospectively be randomized to one of three medications approved for the treatment of endometriosis symptoms.

DRUG

Investigate how Oriahnn, a commonly used medication used to treat symptoms of endometriosis, impact biomarkers of brain health

Eligible participants will prospectively be randomized to one of three medications approved for the treatment of endometriosis symptoms.

Sponsors & Collaborators

  • University of Colorado, Denver

    collaborator OTHER

  • Colorado State University

    lead OTHER

Principal Investigators

  • Lyndsey DuBose, PhD · Colorado State University

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-10-01
Primary Completion
2029-04-30
Completion
2029-06-30
FDA Drug
Yes

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07799246 on ClinicalTrials.gov